Minaxi P. Jhawer, MD

Hematology, Oncology

 I strongly believe empowering my patients and their family with the knowledge of their diagnosis and treatment options is integral to their care. I strive to personalize and individualize the treatment options for each patient.  

Locations & Appointments

Languages Spoken

Gujrati, Hindi

Show Menu

Primary Areas of Practice

  • Hematology
  • Oncology

Other Areas of Practice

  • Bloodless Medicine
  • Cancer Prevention
  • Integrative Medicine
  • Palliative Care

Procedures

  • Cancer Pain Management
  • Chemotherapy
  • Immunotherapy
  • Infusion Therapy
  • Intrathecal Therapy
  • Plasmapheresis and Exchange
  • Targeted Therapy

Conditions Treated

  • Anal Cancer
  • Appendix Cancer
  • Bile Duct Cancer
  • Cholangiocarcinoma
  • Colon Cancer
  • Colorectal Cancer
  • Esophageal Cancer
  • Gallbladder Cancer
  • Gastroesophageal Junction (GEJ) Cancer
  • Gastrointestinal Cancer
  • Liver Cancer
  • Pancreatic Cancer
  • Peritoneal Cancer
  • Rectal Cancer
  • Stomach Cancer

Locations

  • Hematology Oncology Physicians of Englewood, PA

    A

    350 Engle Street 6th Floor, Berrie Center Englewood, NJ 07631

    Main: 201-568-5250
    Fax: 201-568-5358
    Monday
    8:30 AM
    5:00 PM
    Tuesday
    8:30 AM
    5:00 PM
    Wednesday
    8:30 AM
    5:00 PM
    Thursday
    8:30 AM
    12:00 PM
    Friday
    8:30 AM
    5:00 PM

Insurances Accepted

Below is a list of the insurance plans that your provider participates in. It is very important that you contact your insurance company prior to receiving services or care. Each health insurance plan is different and some provide different levels of coverage: only your health insurance plan can provide complete information regarding your coverage and potential out-of-pocket costs.

1199 (SEIU)

  • 1199 (SEIU)

Aetna

  • Aetna HMO
  • Aetna Medicare Managed Care
  • Aetna POS
  • Aetna PPO
  • Medsolutions
  • Meritan Health

Amerigroup

  • Amerigroup Medicaid
  • Amerivantage

AmeriHealth

  • AmeriHealth Administrator
  • AmeriHealth HMO
  • AmeriHealth PPO
  • Value Network (Exchange Plan)

APWU

  • APWU Health Plan

Cigna

  • Cigna HMO
  • Cigna PPO
  • Cigna Supplemental
  • Great-West Healthcare (GWH)
  • Health Partners

Clover Health

  • Clover Health

Consumer Health Network (CHN)

  • CHN PPO

CoreSource

  • CoreSource

Coventry

  • CCN

EmblemHealth

  • EmblemHealth EPO
  • EmblemHealth EPO2
  • EmblemHealth FEHB
  • EmblemHealth FEHBP
  • EmblemHealth GHI CBP
  • EmblemHealth GHI PPO
  • EmblemHealth National
  • EmblemHealth PPO1
  • EmblemHealth PPO2
  • EmblemHealth PPO3
  • EmblemHealth Tri-State
  • Vytra

Empire BCBS

  • Blue Access Network
  • Blue Priority
  • Direct HMO
  • Direct PPO
  • Empire BCBS EPO
  • Empire BCBS HMO
  • Empire BCBS POS
  • Empire BCBS PPO
  • Pathway EPO
  • Pathway HMO
  • Prism
  • Silver
  • Total Blue

Empire Plan (NYSHIP)

  • Empire Plan (NYSHIP)

First Health

  • First Health

Galaxy Health Network PPO

  • Galaxy Health Network PPO

GEHA

  • GEHA Health Plan

Horizon BCBS

  • Federal Employee Program
  • Horizon BCBS EPO
  • Horizon BCBS HMO
  • Horizon BCBS Medicare Managed Care
  • Horizon BCBS PPO
  • NJ Carpenters Fund
  • OMNIA Tier 1
  • Traditional

Horizon NJ Health

  • Horizon NJ Health Medicaid

MagnaCare

  • Local 825
  • MagnaCare PPO

Mail Handlers

  • Mail Handlers Benefit Plan (MHBP)

Medicaid

  • Medicaid NJ

Medicare

  • Medicare NJ

MultiPlan/PHCS

  • Beech Street
  • MultiPlan Humana
  • MultiPlan Worker's Comp
  • PHCS
  • Pomco

MVP Health Care

  • MVP Health Care PPO

NALC

  • NALC Health Benefit Plan

Nippon Life Insurance Co of America

  • Nippon Life Benefits

Oxford

  • Freedom
  • Garden State Network
  • Liberty
  • Metro
  • Oxford Medicare

QualCare

  • Choice Care
  • HIP HMO
  • HIP PPO
  • HIP PRIME HMO
  • HIP PRIME PPO
  • Oscar
  • QualCare EPO
  • QualCare FEHB
  • QualCare GHI PPO
  • QualCare HMO
  • QualCare Humana
  • QualCare PPO
  • QualCare Worker's Comp

Railroad Medicare

  • Railroad Medicare NJ

Transparent Health Network

  • Transparent Health Network

TRICARE North Region

  • CHAMPVA
  • DVA

UMR

  • UMR

United Healthcare Community and State

  • Dual Complete
  • United Healthcare Community and State Medicaid (NJ Family Care)
  • United Healthcare Community and State Medicare

UnitedHealthcare

  • AARP
  • Commercial and Marketplace
  • Compass Benefit (Exchange)
  • Medica
  • River Valley
  • UnitedHealthcare EPO
  • UnitedHealthcare HMO
  • UnitedHealthcare POS
  • UnitedHealthcare PPO
  • UnitedHealthcare StudentResources

Wellcare

  • Wellcare Medicaid Managed Care
  • Wellcare Medicare Managed Care

About Minaxi Jhawer

Dr. Jhawer is chief of hematology/oncology. She is board certified in internal medicine, medical oncology, and hematology and specializes in cancers of the esophagus, stomach, small bowel, liver and bile ducts (hepatobiliary tract), pancreas, colon, and rectum. Dr. Jhawer completed postdoctoral fellowship training at Johns Hopkins University. After her residency and fellowship at Albert Einstein College of Medicine, she served on the gastrointestinal medical oncology faculty at Memorial Sloan Kettering Cancer Center. She developed and co-led EHMC's disease management team in gastroenterology and hepatobiliary cancer. She co-leads the multidisciplinary cancer conferences for patients diagnosed with GI cancer.

Dr. Jhawer collaborates with colleagues from New York City hospitals on caring for oncology patients and on clinical trials. She has been a principal investigator on many clinical trials and has presented her work at national conferences and been published in peer-reviewed journals. Dr. Jhawer is a member of the American Society of Clinical Oncology, the American Society of Hematology, and the American Association for Cancer Research. She was recently appointed to the Clinical Practice Guidelines Committee of the American Society of Clinical Oncology. Dr. Jhawer is active in medical education and community outreach programs. She is involved in development of the survivorship plan, palliative care in the outpatient setting, and integrative medicine atEnglewood Health's Graf Center for Integrative Medicine.

Honors & Awards

2020, 2019, 2017: Bergen Magazine Top Doctors

2020-2016: Castle Connolly Top Doctors New York Metro Area

2019: Exceptional Women in Medicine

2019-2017: Jersey's Best: Top Doctors for Cancer

2019-2015: Jersey's Best Magazine Top Doctors

2018, 2017, 2015: New York Magazine Best Doctors

2018: New Jersey Monthly Magazine Top Doctor

2017: Americas Most Honored Top 1% Professionals

2015: Life and Living Show- Interview 5/20/15

2015: 201 Magazine Top Doctors-Top 20 People to Watch in Health Care

Professional Memberships

American Society of Clinical Oncology

American Society of Hematology

American Medical Association

American Association for Cancer Research

Bergen Indian Medical Association

Committees and Leadership Positions

Section Chief, Hematology/Oncology

2017 - 2020: Member, American Society of Clinical Oncology Clinical Practice Guidelines Committee

2017: Elected to Medical Executive Committee

2016 - present: Bylaws Committee

2014 - present: Advisory Board for Integrative Medicine Department

2014 - present: Medical Advisory Board for Kula for Karma

Co-Leader for Upper, Lower GI and Hepatobiliary Tumor Board and DMT

Established Funding for Complementary Yoga Program for Englewood Hospital Cancer Patients and Their Caregivers

Survivorship Program for Patients with Curable Cancers

Established Pain and Palliative Consultation and Care in the Outpatient Oncology Setting

Global Health and Community Health Activities

Korean /Asian population screening for GI cancers

Education & Degrees

MD: Dr. D.Y. Patil Medical College

Residency

Albert Einstein College of Medicine - Jacobi Medical Center

Fellowship

Montefiore Hospital and Medical Center

Board Certifications

  • Hematology
  • Medical Oncology

Publications

Klute KA, Brouwer J, Jhawer M, et al. Chemotherapy dose intensity predicted by baseline nutrition assessment in gastrointestinal malignancies: A multicenter analysis. Eur J Cancer. 2016 Aug;63:189-200

Shah MA, Jhawer M, Ilson D, Lekowitz RA et al. Phase II study of modified docetaxel, cisplatin,and fluorouracil with bevacizumab in patients with metastatic gastroesophageal adenocarcinoma. J Clin Oncol 2011 Mar 1;29(7):868-74

Wilson AK, Cheuh AC, Togel L, Corner GA, Ahmed N, Goel S, Byun DS, Nasser S, Houston MA, Jhawer M et al. Apoptotic sensitivity of colon cancer cell lines to histone deacetylase inhibitors is mediated by sp1/sp3 activated transcriptional program involving immediate early gene induction. Cancer Res 2010 Jan 15; 70(2):609-20

Yuan Z, Shin J, Wilson A, Goel S, Ahmed N, Dopeso H, Jhawer M, et al. An A13 repeat within the 3-untranslated region of epidermal growth factor receptor (EGFR) is frequently mutated in microsatellite instability colon cancers and is associated with increased EGFR expression. Cancer Res 2009 Oct 1;69(19):7811-8

Jhawer M, Coit D, Brennan M, Qin L, Gonen M, Klimstra D, Tang L, Kelsen D, Shah MA. Perineural invasion following preoperative chemotherapy predicts poor survival in patients with locally advanced gastric cancer: gene expression analysis with pathologic validation. Am J Clin Oncol. 2009 Aug;32(4):356-62

Jhawer M, Goel S, Wilson AJ, Montagna C, Ling YH et al. PIK3CA mutation/ PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab. Cancer Res.2008 Mar 15;68(6):1953-61

Jhawer M, Kelsen D, Shah M. Incorporation of biologic therapies in the management of gastroesophageal cancers. Gastrointest Cancer Res. 2007 Mar; 1(2 suppl): S22-9

Jhawer M, Rosen L, Dancey J, Hochster H, Hamburg S, Tempero M, et al. Phase II Trial of Nolatrexed Dihydrochloride [ThymitaqTM, AG 337] in Patients with Advanced Hepatocellular Carcinoma. Investigational New Drugs 2007 Feb 25(1):85-94

Jhawer M, Mani S, Lefkopoulou M, Hahn R, Harris J, et al. Phase II study of Mitomycin-C, Adriamycin, Cisplatin and Bleomycin-CCNU in patients with advanced anal canal cancer: An ECOG study, E 7282. Investigational New Drugs 2006 Sep; 24(5):447-54

Goel S, Jhawer M, Sparano J, Mani S, et al Phase I clinical trial of the combination of irinotecan and oral capecitabine in patients with solid malignancies. Am J Clin Oncol. 2002 Oct; 25(5):528-34

For a full listing of Dr. Jhawer's publications, please visit PubMed.gov

Important COVID-19 Information for Our Patients, Visitors, and Community

More